Key Points Johnson & Johnson has a rare and impressive streak of consecutive annual dividend increases. Merck is facing multiple challenges, but it is demonstrating that it can overcome them. 10 stocks we like better than Johnson & Johnson › Dividend investing will never go out of style. It's one of the best ways to take advantage of the magic of compounding (by reinvesting dividends), which can significantly boost long-term returns. And there is evidence that, over the past few decades, dividend-paying stocks have significantly outperformed non-dividend payers. But choosing a random income stock won't do -- they aren't all created equal.
Головну думку ми показуємо публічно. Створіть безкоштовний акаунт, щоб читати повну статтю, зберігати її, обговорювати та поєднувати з ринковим і OSINT-контекстом.
